Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
25 July 2022 | Story Lunga Luthuli

From an early age, many have been taught that strangers are not only a danger to the individual, but to the communities too.

A StrangerKind (ASK), an organisation hosting unconventional conversations in communities on topics and responding to questions that many may not have the opportunity to ask, has partnered with the University of the Free State to host the talks that aims to promote curiosity, diversity, and social cohesion.

As part of the ASKcampus – a first to be hosted at any university in the country – participants will have an opportunity to talk to a stranger in a safe setting and ask any question that comes to mind, without any judgement.

Michelle Nöthling, Assistant Researcher in Kovsie Support Services, said: “The ASK event is an opportunity for participants to pick a topic from a list that sparks curiosity and book an available 45-minute time slot. During your session, you sit down to a one-on-one conversation with a stranger who will briefly introduce themselves and their topic. They will then share their personal life experience on that topic with you.”

The event, which will be launched at the Thakaneng Bridge, Bloemfontein Campus, on 28 July 2022, is open to both UFS staff and students.

“During the individual sessions, participants may ask the strangers anything about the chosen topic. We even encourage you to ask those questions that you might otherwise have been too shy, or felt were too ignorant, to ask. What is more, is that the strangers you will meet will be fellow UFS staff and students. But you will not know who your stranger is until you sit down with them,” said Michelle.

Individuals who want to know more about becoming a UFS stranger are encouraged to visit the organisation’s YouTube channel or register to attend training and become a ‘stranger’.

Be curious. Be brave. Talk to strangers.

Launch details:
Date
: 28 July 2022
Time
: 10:00-14:00
Venue
: Thakaneng Bridge, Bloemfontein Campus

News Archive

Haemophilia home infusion workshop
2017-12-17


 Description: haemophilia Tags: Haemophilia, community, patient, clinical skills, training 

Parents receive training for homecare of their children with haemophilia.
Photo Supplied


Caregivers for haemophilia patients, and patients themselves from around the Free State and Northern Cape attended a home infusion workshop held by the Clinical Skills unit in the Faculty of Health Sciences in July 2017. “It felt liberating and I feel confident to give the factor to my son correctly,” said Amanda Chaba-Okeke, the mother of a young patient, at the workshop. Her son, also at the workshop, agreed. “It felt lovely and good to learn how to administer factor VIII.” 

Clinical skills to empower parents and communities

There were two concurrent sessions: one attended by doctors from the Haemophilia Treatment Centre, and the other attended by community members including factor VIII and XI recipients, caregivers and parents. The doctors’ meeting was shown informative videos and demonstrations on how to administer the newly devised factor VII and XI kit, and discussed the pressing need for trained nurses at local clinics. Dr Jaco Joubert, a haematologist, made an educational presentation to the community members.

The South African Haemophilia Foundation was represented by Mahlomola Sewolane, who gave a brief talk about the role of the organisation in relation to the condition. Meanwhile, procedural training in the simulation laboratory involved doctors and nurses helping participants to learn the procedures by using mannequins and even some volunteers from among the patients.

A medical condition causing serious complications
Haemophilia is a medical condition in which the ability of the blood to clot is severely impaired, even from a slight injury. The condition is typically caused by a hereditary lack of a coagulation factor, most often factor VIII. Usually patients must go through replacement therapy in which concentrates of clotting factor VIII (for haemophilia A) or clotting factor IX (for haemophilia B) are slowly dripped or injected into the vein, to help replace the clotting factor that is missing or low. Patients have to receive this treatment in hospital.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept